Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.14 USD | +0.99% | -4.06% | -6.97% |
03-06 | Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call | |
03-06 | Norway's wealth fund pushes for more women on emerging market company boards | RE |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 368M 269M 21.45B |
---|---|---|---|---|---|
Net income 2024 * | -48M -35.11M -2.8B | Net income 2025 * | -78M -57.06M -4.54B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.66
x | P/E ratio 2025 * |
-5.45
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.72% |
Latest transcript on ESSA Pharma Inc.
1 day | +0.99% | ||
1 week | -4.06% | ||
Current month | -27.68% | ||
1 month | -27.68% | ||
3 months | -26.56% | ||
6 months | +38.91% | ||
Current year | -6.97% |
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 23/06/15 |
David Wood
DFI | Director of Finance/CFO | 66 | 30/09/13 |
Peter Virsik
COO | Chief Operating Officer | - | 31/07/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 04/03/15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 30/07/19 |
Richard Glickman
CHM | Chairman | 65 | 30/09/10 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 6.14 | +0.99% | 147,492 |
26/04/24 | 6.08 | -0.65% | 178,467 |
25/04/24 | 6.12 | -2.08% | 64,770 |
24/04/24 | 6.25 | -2.34% | 41,308 |
23/04/24 | 6.4 | 0.00% | 130,486 |
Delayed Quote Nasdaq, April 29, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.97% | 269M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- EPIX Stock